Medical Information Library

*required fields

By searching, I confirm my enquiry is unsolicited & the results may provide information outside the product label.
Log In / Register to access results

Orencia® (abatacept) Information

UK (Great Britain)

Orencia® (abatacept) 50 mg solution for injection (pre-filled syringe)
Orencia® (abatacept) 87.5 mg solution for injection (pre-filled syringe)
Orencia® (abatacept) 125 mg Solution for Injection (pre-filled syringe)
Orencia® (abatacept) 125 mg Solution for Injection (pre-filled pen)
Orencia® (abatacept) 250 mg Powder for Concentrate for Solution for Infusion

UK (Northern Ireland)

Orencia® (abatacept) 50 mg solution for injection (pre-filled syringe)
Orencia® (abatacept) 87.5 mg solution for injection (pre-filled syringe)
Orencia® (abatacept) 125 mg Solution for Injection (pre-filled syringe)
Orencia® (abatacept) 125 mg Solution for Injection (pre-filled pen)
Orencia® (abatacept) 250 mg Powder for Concentrate for Solution for Infusion

Call BMS

Medical Information

0800 7311 736

0800 7311 736

Adverse Event or Product Quality Complaints


0800 7311 736

0800 7311 736


Global Medical Information

Not from the UK? Use our Global Medical Information website to submit a medical enquiry, report an adverse event or product quality complaint to a medical information professional in your country.

Visit Site

Submit a Medical Enquiry

Submit your question to our team of medical professionals. Bristol-Myers Squibb is dedicated to responding to all enquiries as quickly and accurately as possible.

Submit Question

You may contact our EU Data Protection Officer at EUDPO@BMS.com to exercise any data privacy rights that you may have, as well as to raise any concerns or questions in relation to the handling of your personal data by Bristol Myers Squibb Company.

Bristol Myers Squibb Pharmaceuticals Limited
ARC Uxbridge Sanderson Road
New Denham, Denham Buckinghamshire
London, England UB8 1DH, GB
© 2022 Bristol Myers Squibb Company
466-GB-2300055 11/2023